Showing results (731-740 of 828) with videos related to

Sort By:
Pageof 83
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 6, 2018
Circulating Tumor DNA Analysis in Patients With Cancer: American Society of Clinical Oncology and College of American Pathologists Joint ReviewJason D Merker, Geoffrey R Oxnard, Carolyn Compton, et al.
Cancer Treatment Reviews|February 1, 2008
Dose-escalation of filgrastim does not improve efficacy: clinical tolerability and long-term follow-up on CALGB study 9141 adjuvant chemotherapy for node-positive breast cancer patients using dose-intensified doxorubicin plus cyclophosphamide followed by paclitaxelMinetta C Liu, George D Demetri, Donald A Berry, et al.
NPJ Breast Cancer|March 11, 2022
Estrogen receptor inhibition mediates radiosensitization of ER-positive breast cancer modelsAnna R Michmerhuizen, Lynn M Lerner, Andrea M Pesch, et al.
Cancer Cytopathology|March 25, 2011
Biospecimen reporting for improved study quality (BRISQ)Helen M Moore, Andrea B Kelly, Scott D Jewell, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 23, 2011
p53 Expression in node-positive breast cancer patients: results from the Cancer and Leukemia Group B 9344 Trial (159905)Jonathan F Lara, Ann D Thor, Lynn G Dressler, et al.
Archives of Pathology & Laboratory Medicine|March 6, 2018
Circulating Tumor DNA Analysis in Patients With Cancer: American Society of Clinical Oncology and College of American Pathologists Joint ReviewJason D Merker, Geoffrey R Oxnard, Carolyn Compton, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 30, 2021
A Randomized Trial of Fulvestrant, Everolimus, and Anastrozole for the Front-line Treatment of Patients with Advanced Hormone Receptor-positive Breast Cancer, SWOG S1222Halle C F Moore, William E Barlow, George Somlo, et al.
Cancer Research|February 18, 2017
Targeted Degradation of BET Proteins in Triple-Negative Breast CancerLongchuan Bai, Bing Zhou, Chao-Yie Yang, et al.
Nature Communications|August 17, 2023
Gabapentinoid consumption in 65 countries and regions from 2008 to 2018: a longitudinal trend studyAdrienne Y L Chan, Andrew S C Yuen, Daniel H T Tsai, et al.
Breast Cancer Research and Treatment|May 13, 2018
A phase II study evaluating the efficacy of zoledronic acid in prevention of aromatase inhibitor-associated musculoskeletal symptoms: the ZAP trialCesar A Santa-Maria, Aditya Bardia, Amanda L Blackford, et al.
Pageof 83